CDC Chronic Disease Prevention Programs
Chronic diseases account for the majority of deaths and disability in the United States, making their prevention a central pillar of federal public health strategy. The Centers for Disease Control and Prevention administers a portfolio of programs specifically designed to reduce the burden of conditions such as heart disease, diabetes, cancer, obesity, and stroke. This page covers the definition and scope of CDC chronic disease prevention efforts, the mechanisms through which programs operate, common intervention scenarios, and the decision boundaries that determine how and where resources are directed.
Definition and scope
CDC chronic disease prevention programs are federally funded public health initiatives designed to reduce incidence, morbidity, and mortality from non-communicable conditions through surveillance, education, policy support, and direct intervention at population scale. These programs operate under the National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), which is one of the primary operational centers within CDC's organizational structure.
The scope of NCCDPHP activity spans six leading chronic disease domains recognized by CDC:
- Cardiovascular disease and stroke — including hypertension management and Million Hearts® initiative targets
- Diabetes — encompassing the National Diabetes Prevention Program (National DPP), which delivers structured lifestyle change interventions
- Cancer — through screening programs such as the National Breast and Cervical Cancer Early Detection Program (NBCCEDP)
- Obesity and nutrition — including the REACH program targeting racial and ethnic health disparities
- Tobacco and smoking — through the Office on Smoking and Health (OSH) and the Tips From Former Smokers® campaign
- Oral health — including community water fluoridation monitoring and school-based sealant programs
Chronic diseases are responsible for approximately 7 in 10 deaths in the United States each year (CDC NCCDPHP, About Chronic Diseases), and they drive a disproportionate share of the nation's $4.5 trillion in annual health expenditures (CDC, Health and Economic Costs of Chronic Diseases).
The NCCDPHP does not operate independently — its programs connect directly to CDC's state and local partnerships, through which federal funding flows to health departments across all 50 states, the District of Columbia, and U.S. territories.
How it works
Program delivery follows a multi-level model that distinguishes between upstream policy-level interventions and downstream individual-level services.
At the policy and systems level, CDC provides technical assistance and funding for states to adopt clinical-community linkage models, improve built environment conditions (such as walkability standards), and expand access to preventive medications. The State Physical Activity and Nutrition (SPAN) program exemplifies this approach by funding 16 states (as of the most recently awarded grant cohort) to implement population-wide nutrition and physical activity strategies.
At the clinical and community level, programs such as the National DPP use a recognized lifestyle change framework in which participants attend structured sessions over 12 months with a trained lifestyle coach. CDC recognition is required for organizations delivering the National DPP — organizations must meet performance standards including a minimum 5% average weight loss among participants and at least 80% of enrolled participants completing at least 4 sessions (CDC, National DPP Recognition Program).
Funding flows primarily through CDC grants and cooperative agreements, using a combination of block grants, program-specific grants, and cooperative agreements. The Racial and Ethnic Approaches to Community Health (REACH) program, for example, awards cooperative agreements specifically to community-based organizations serving populations with demonstrated health disparities.
Surveillance is foundational to all program decisions. Data from the Behavioral Risk Factor Surveillance System (BRFSS), the largest continuously conducted telephone health survey in the world (covering all 50 states and 400,000+ respondents annually), and from the CDC National Health Interview Survey informs resource allocation, target population identification, and outcome measurement.
Common scenarios
Three scenarios illustrate the practical operation of chronic disease prevention programs:
Scenario 1 — State diabetes prevention scale-up. A state health department receives a cooperative agreement from CDC to expand National DPP coverage in rural counties. The department contracts with federally qualified health centers (FQHCs) to deliver the program, tracks enrollment and outcome data in the CDC-maintained registry, and reports results quarterly to CDC program officers. Coverage gaps and outcomes feed back into CDC data and statistics resources for national reporting.
Scenario 2 — Cancer screening for low-income women. The NBCCEDP funds 67 programs across all 50 states, the District of Columbia, five U.S. territories, and 11 tribal organizations (CDC, NBCCEDP Program Information) to provide free mammograms and cervical cancer screenings to women who meet income eligibility thresholds (at or below 250% of the federal poverty level). Women diagnosed with cancer through the program become eligible for treatment funding through a separate Medicaid pathway established under the Breast and Cervical Cancer Prevention and Treatment Act of 2000.
Scenario 3 — Tobacco cessation media campaign. The Tips From Former Smokers® national campaign, funded by CDC's Office on Smoking and Health, runs paid advertising in English and Spanish across television, radio, and digital channels. A 2012–2018 evaluation period documented that the campaign prompted an estimated 1 million smokers to quit (CDC, Tips Campaign Impact).
Decision boundaries
CDC chronic disease prevention programs operate within institutional decision boundaries that determine scope, eligibility, and program design authority.
Federal vs. state authority: CDC holds no direct regulatory authority over state health departments or clinical providers. The agency functions through persuasion, technical assistance, and financial incentives. State participation in programs such as SPAN or REACH is voluntary, though acceptance of CDC cooperative agreement funds binds the recipient to reporting requirements and performance benchmarks defined in the Notice of Award.
Prevention vs. treatment: A clear boundary separates CDC chronic disease prevention programs from treatment and insurance coverage mandates — the latter fall under Centers for Medicare & Medicaid Services (CMS) authority. CDC programs fund screening and lifestyle interventions; treatment funding, where it exists (as in the NBCCEDP-to-Medicaid pathway), is administered by CMS, not CDC.
Population-level vs. individual clinical care: CDC does not prescribe individual clinical care. The agency issues evidence-based guidance (distinct from binding clinical standards), and providers may follow or decline those recommendations. This contrasts with the agency's role in CDC infection control guidelines, where guidance carries stronger institutional weight in healthcare facility accreditation processes.
Equity-targeted vs. universal programming: Programs such as REACH and the CDC health equity programs portfolio use explicit eligibility criteria tied to racial, ethnic, or socioeconomic status. Universal programs such as tobacco campaigns and BRFSS are population-wide and carry no demographic eligibility restrictions. The decision to fund a targeted versus universal program reflects a documented disparity threshold established in the program's authorizing legislation or grant announcement.
The broad scope of CDC's public health mission encompasses these chronic disease programs as one of the agency's largest domestic investment areas, alongside infectious disease surveillance and emergency response. Program design decisions at NCCDPHP must align with the agency's overarching strategic priorities, which are set at the director level and reviewed through congressional appropriations — a process detailed under CDC congressional oversight.